Latest news
Sentinel Node Biopsy Gains Ground in Endometrial Cancer - MedscapeMedscape · Thu, 06 Aug 2026 12:34:12 GMTSelinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - OncLiveOncLive · Fri, 31 Jul 2026 17:22:55 GMTSelinexor Phase 3 Trial Misses Primary Endpoint in Endometrial Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 31 Jul 2026 07:37:59 GMTSelinexor Misses Primary Endpoint in Endometrial Cancer Trial - MPR - Medical Professionals ReferenceMedical Professionals Reference · Fri, 31 Jul 2026 04:00:00 GMTKaryopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - KaryopharmKaryopharm · Thu, 30 Jul 2026 07:00:00 GMTQ&A: Are environmental chemicals and endometrial cancer linked? - The Pennsylvania State UniversityThe Pennsylvania State University · Tue, 28 Jul 2026 07:00:00 GMT